Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
If PIFELTRO is coadministered with rifabutin, increase PIFELTRO dosage to one tablet twice daily (approximately 12 hours apart). Consult the full Prescribing Information prior to and during treatment ...
The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...
Researchers at University Hospital Zurich and the University of Zurich report that intimate physical contact combined with ...
She was shocked to see her hand become red and swollen: "A silly paper cut did all this!" It’s a reminder all cuts can become ...
Cases of scabies – a parasitic skin condition once associated with poor hygiene and crowded living conditions – are on the ...
Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a secondhand high. Called “bluetoothing,” the gruesome movement is fueling a wave of new HIV ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The ongoing monkeypox virus ...
Los Angeles Angels star Mike Trout was scratched from the starting lineup Tuesday against the host Kansas City Royals due to a skin infection, according to the team. No further details were given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback